Trial record 1 of 1 for:    cdx-353-002
Previous Study | Return to List | Next Study

Safety and Efficacy Study of High Dose Melphalan HCL for Injection (Propylene Glycol-Free) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01660633
Recruitment Status : Completed
First Posted : August 9, 2012
Last Update Posted : June 2, 2015
Clinipace LTD
Kansas City Bioanalytical Laboratories
Beckloff Associates, Inc.
Information provided by (Responsible Party):
Spectrum Pharmaceuticals, Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : February 2014
  Study Completion Date : August 2014
  Certification/Extension First Submitted : February 13, 2015